Pliant Therapeutics, Inc.
PLRX
$1.07
-$0.01-0.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.04M | -23.58M | -26.30M | -43.30M | -56.17M |
| Total Depreciation and Amortization | 264.00K | 365.00K | 436.00K | 447.00K | 448.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.41M | 7.46M | 7.53M | 9.17M | 11.09M |
| Change in Net Operating Assets | -4.87M | -2.04M | -2.75M | -6.92M | -4.23M |
| Cash from Operations | -19.23M | -17.79M | -21.08M | -40.60M | -48.86M |
| Capital Expenditure | -- | 0.00 | 0.00 | -112.00K | -262.00K |
| Sale of Property, Plant, and Equipment | 102.00K | -1.00K | 156.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.20M | 1.77M | 27.77M | 35.60M | 69.38M |
| Cash from Investing | -4.10M | 1.77M | 27.92M | 35.49M | 69.11M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -32.27M | -- | -- | -- |
| Issuance of Common Stock | 74.00K | 0.00 | 72.00K | 0.00 | 498.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 74.00K | -32.27M | 72.00K | 0.00 | 498.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.26M | -48.29M | 6.91M | -5.12M | 20.75M |